Search by Drug Name or NDC
NDC 00054-3566-99 Midazolam Hydrochloride 2 mg/mL Details
Midazolam Hydrochloride 2 mg/mL
Midazolam Hydrochloride is a ORAL SYRUP in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is MIDAZOLAM HYDROCHLORIDE.
MedlinePlus Drug Summary
Midazolam is given to children before medical procedures or before anesthesia for surgery to cause drowsiness, relieve anxiety, and prevent any memory of the event. Midazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow relaxation and sleep.
Related Packages: 00054-3566-99Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Midazolam
Product Information
| NDC | 00054-3566 |
|---|---|
| Product ID | 0054-3566_83e0ae08-f443-4c83-a995-5f2efd5b43ff |
| Associated GPIs | 60201025101220 |
| GCN Sequence Number | 040822 |
| GCN Sequence Number Description | midazolam HCl SYRUP 2 MG/ML ORAL |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 40852 |
| HICL Sequence Number | 001619 |
| HICL Sequence Number Description | MIDAZOLAM HCL |
| Brand/Generic | Generic |
| Proprietary Name | Midazolam Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Midazolam Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SYRUP |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | MIDAZOLAM HYDROCHLORIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA075873 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-3566-99 (00054356699)
| NDC Package Code | 0054-3566-99 |
|---|---|
| Billing NDC | 00054356699 |
| Package | 118 mL in 1 BOTTLE, GLASS (0054-3566-99) |
| Marketing Start Date | 2002-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.65453 |
| Pricing Unit | ML |
| Effective Date | 2022-08-17 |
| NDC Description | MIDAZOLAM HCL 2 MG/ML SYRUP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis